The importance of studying cell metabolism when testing the bioactivity of phenolic compounds

Trends in Food Science and Technology

Volumn 69, Issue , 2017, Pages 230-242

  Aragonès, Gerard ^a   Danesi, Francesca ^b   Del Rio, Daniele ^c   Mena, Pedro ^c  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Cell media; Colonic metabolite; Dietary (poly)phenol; In vitro study; Peripheral metabolism; Phase II conjugation

Indexed keywords

BIOACTIVITY; BIOMOLECULES; CELL CULTURE; METABOLISM; METABOLITES; MOLECULES; PHENOLS;

BIOLOGICAL PROPERTIES; EXPERIMENTAL MODELS; IN-VITRO; METABOLIC TRANSFORMATIONS; PHASE II; PHENOLIC METABOLITES; PRACTICAL RECOMMENDATION; STRUCTURE OF MOLECULES;

CELLS;

EID: 85013658449     PISSN: 09242244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tifs.2017.02.001     Document Type: Article

References (64)

1. el-Bacha, R.S., Minn, A., Drug metabolizing enzymes in cerebrovascular endothelial cells afford a metabolic protection to the brain. Cellular and Molecular Biology 45 (1999), 15–23.
2. Barrington, R., Williamson, G., Bennett, R.N., Davis, B.D., Brodbelt, J.S., Kroon, P.A., Absorption, conjugation and efflux of the flavonoids, kaempferol and galangin, using the intestinal CaCo-2/TC7 cell model. Journal of Functional Foods 1 (2009), 74–87.
3. Bladé, C., Aragonès, G., Arola-Arnal, A., Muguerza, B., Bravo, F.I., Salvadó, M.J., et al. Proanthocyanidins in health and disease. BioFactors 42 (2016), 5–12.
4. de Boer, V.C., de Goffau, M.C., Arts, I.C., Hollman, P.C., Keijer, J., SIRT1 stimulation by polyphenols is affected by their stability and metabolism. Mechanisms of Ageing and Development 127 (2006), 618–627.
5. Brand, W., van der Wel, P.A., Rein, M.J., Barron, D., Williamson, G., van Bladeren, P.J., et al. Metabolism and transport of the citrus flavonoid hesperetin in Caco-2 cell monolayers. Drug Metabolism and Disposition 36 (2008), 1794–1802.
6. Chen, J., Lin, H., Hu, M., Absorption and metabolism of genistein and its five isoflavone analogs in the human intestinal Caco-2 model. Cancer Chemotherapy and Pharmacology 55 (2005), 159–169.
7. Dall'Asta, M., Derlindati, E., Curella, V., Mena, P., Calani, L., Ray, S., et al. Effects of naringenin and its phase II metabolites on in vitro human macrophage gene expression. International Journal of Food Sciences and Nutrition 64 (2013), 843–849.
8. Day, A.J., Bao, Y., Morgan, M.R., Williamson, G., Conjugation position of quercetin glucuronides and effect on biological activity. Free Radical Biology and Medicine 29 (2000), 1234–1243.
9. del Mar Contreras, M., Borrás-Linares, I., Herranz-López, M., Micol, V., Segura-Carretero, A., Further exploring the absorption and enterocyte metabolism of quercetin forms in the Caco-2 model using nano-LC-TOF-MS. Electrophoresis 37 (2016), 998–1006.
10. Del Rio, D., Rodríguez-Mateos, A., Spencer, J.P.E., Tognolini, M., Borges, G., Crozier, A., Dietary (poly)phenolics in human health: Structures, bioavailability, and evidence of protective effects against chronic diseases. Antioxidants and Redox Signaling 18 (2013), 1818–1892.
11. Dellafiora, L., Mena, P., Cozzini, P., Brighenti, F., Del Rio, D., Modelling the possible bioactivity of ellagitannin-derived metabolites. in silico tools to evaluate their potential xenoestrogenic behavior. Food and Function 4 (2013), 1442–1451.
12. Doms, A., Schroeder, M., GoPubMed: Exploring PubMed with the gene ontology. Nucleic Acids Research 33 (2005), W783–W786.
13. García-Villalba, R., Carrasco-Pancorbo, A., Oliveras-Ferraros, C., Menéndez, J.A., Segura-Carretero, A., Fernández-Gutiérrez, A., Uptake and metabolism of olive oil polyphenols in human breast cancer cells using nano-liquid chromatography coupled to electrospray ionization-time of flight-mass spectrometry. Journal of Chromatography B: Analytical Technologies in the Biomedical and Life Sciences 898 (2012), 69–77.
14. Giménez-Bastida, J.A., González-Sarrías, A., Larrosa, M., Tomás-Barberán, F., Espín, J.C., García-Conesa, M.T., Ellagitannin metabolites, urolithin A glucuronide and its aglycone urolithin A, ameliorate TNF-α-induced inflammation and associated molecular markers in human aortic endothelial cells. Molecular Nutrition and Food Research 56 (2012), 784–796.
15. Giménez-Bastida, J.A., González-Sarrías, A., Vallejo, F., Espín, J.C., Tomás-Barberán, F.A., Hesperetin and its sulfate and glucuronide metabolites inhibit TNF-α induced human aortic endothelial cell migration and decrease plasminogen activator inhibitor-1 (PAI-1) levels. Food and Function 7 (2016), 118–126.
16. González-Sarrías, A., Azorín-Ortuño, M., Yáñez-Gascón, M.J., Tomás-Barberán, F.A., García-Conesa, M.T., Espín, J.C., Dissimilar in vitro and in vivo effects of ellagic acid and its microbiota-derived metabolites, urolithins, on the cytochrome P450 1A1. Journal of Agricultural and Food Chemistry 57 (2009), 5623–5632.
17. González-Sarrías, A., Giménez-Bastida, J.A., Núñez-Sánchez, M.Á., Larrosa, M., García-Conesa, M.T., Tomás-Barberán, F.A., et al. Phase-II metabolism limits the antiproliferative activity of urolithins in human colon cancer cells. European Journal of Nutrition 53 (2014), 853–864.
18. González-Sarrías, A., Larrosa, M., Tomás-Barberán, F.A., Dolara, P., Espín, J.C., NF-κB-dependent anti-inflammatory activity of urolithins, gut microbiota ellagic acid-derived metabolites, in human colonic fibroblasts. The British Journal of Nutrition 104 (2010), 503–512.
19. González-Sarrías, A., Núñez-Sánchez, M.Á., García-Villalba, R., Tomás-Barberán, F.A., Espín, J.C., Antiproliferative activity of the ellagic acid-derived gut microbiota isourolithin A and comparison with its urolithin A isomer: The role of cell metabolism. European Journal of Nutrition, 2015, 10.1007/s00394-015-1131-7.
20. Gradolatto, A., Canivenc-Lavier, M.C., Basly, J.P., Siess, M.H., Teyssier, C., Metabolism of apigenin by rat liver phase I and phase II enzymes and by isolated perfused rat liver. Drug Metabolism and Disposition 32 (2004), 58–65.
21. Hempel, N., Wang, H., LeCluyse, E.L., McManus, M.E., Negishi, M., The human sulfotransferase SULT1A1 gene is regulated in a synergistic manner by Sp1 and GA binding protein. Molecular Pharmacology 66 (2004), 1690–1701.
22. Hong, J., Lu, H., Meng, X., Ryu, J.H., Hara, Y., Yang, C.S., Stability, cellular uptake, biotransformation, and efflux of tea polyphenol (−)-epigallocatechin-3-gallate in HT-29 human colon adenocarcinoma cells. Cancer Research 62 (2002), 7241–7246.
23. Hoshino, J., Park, E.J., Kondratyuk, T.P., Marler, L., Pezzuto, J.M., van Breemen, R.B., et al. Selective synthesis and biological evaluation of sulfate-conjugated resveratrol metabolites. Journal of Medicinal Chemistry 53 (2010), 5033–5043.
24. Ishisaka, A., Kawabata, K., Miki, S., Shiba, Y., Minekawa, S., Nishikawa, T., et al. Mitochondrial dysfunction leads to deconjugation of quercetin glucuronides in inflammatory macrophages. PLoS One, 8, 2013, e80843.
25. Kahle, K., Kempf, M., Schreier, P., Scheppach, W., Schrenk, D., Kautenburger, T., et al. Intestinal transit and systemic metabolism of apple polyphenols. European Journal of Nutrition 50 (2011), 507–522.
26. Kaldas, M.I., Walle, U.K., Walle, T., Resveratrol transport and metabolism by human intestinal Caco-2 cells. The Journal of Pharmacy and Pharmacology 55 (2003), 307–312.
27. Kawai, Y., Nishikawa, T., Shiba, Y., Saito, S., Murota, K., Shibata, N., et al. Macrophage as a target of quercetin glucuronides in human atherosclerotic arteries: Implication in the anti-atherosclerotic mechanism of dietary flavonoids. Journal of Biological Chemistry 283 (2008), 9424–9434.
28. Kay, C.D., Kroon, P.A., Cassidy, A., The bioactivity of dietary anthocyanins is likely to be mediated by their degradation products. Molecular Nutrition and Food Research 53 (2009), S92–S101.
29. Kern, S.M., Bennett, R.N., Needs, P.W., Mellon, F.A., Kroon, P.A., García-Conesa, M.T., Characterization of metabolites of hydroxycinnamates in the in vitro model of human small intestinal epithelium Caco-2 cells. Journal of Agricultural and Food Chemistry 51 (2003), 7884–7891.
30. Lançon, A., Hanet, N., Jannin, B., Delmas, D., Heydel, J.M., Lizard, G., et al. Resveratrol in human hepatoma HepG2 cells: Metabolism and inducibility of detoxifying enzymes. Drug Metabolism and Disposition 35 (2007), 699–703.
31. Larrosa, M., González-Sarrías, A., García-Conesa, M.T., Tomás-Barberán, F.A., Espín, J.C., Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. Journal of Agricultural and Food Chemistry 54 (2006), 1611–1620.
32. Larrosa, M., Tomás-Barberán, F.A., Espín, J.C., The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. Journal of Nutritional Biochemistry 17 (2006), 611–625.
33. Mateos, R., Goya, L., Bravo, L., Uptake and metabolism of hydroxycinnamic acids (chlorogenic, caffeic, and ferulic acids) by HepG2 cells as a model of the human liver. Journal of Agricultural and Food Chemistry 54 (2006), 8724–8732.
34. Mele, L., Mena, P., Piemontese, A., Marino, V., López-Gutiérrez, N., Bernini, F., et al. Antiatherogenic effects of ellagic acid and urolithins in vitro. Archives of Biochemistry and Biophysics 599 (2016), 42–50.
35. Mena, P., Calani, L., Bruni, R., Del Rio, D., Chapter 6-bioactivation of high-molecular-weight polyphenols by the gut microbiome. Tuohy, K., Del Rio, D., (eds.) Diet-microbe interactions in the gut, 2015, Academic Press, San Diego, 73–101.
36. Mülek, M., Fekete, A., Wiest, J., Holzgrabe, U., Mueller, M.J., Högger, P., Profiling a gut microbiota-generated catechin metabolite's fate in human blood cells using a metabolomic approach. Journal of Pharmaceutical and Biomedical Analysis 114 (2015), 71–81.
37. Murota, K., Shimizu, S., Chujo, H., Moon, J.H., Terao, J., Efficiency of absorption and metabolic conversion of quercetin and its glucosides in human intestinal cell line Caco-2. Archives of Biochemistry and Biophysics 384 (2000), 391–397.
38. Ng, S.P., Wong, K.Y., Zhang, L., Zuo, Z., Lin, G., Evaluation of the first-pass glucuronidation of selected flavones in gut by Caco-2 monolayer model. Journal of Pharmacy and Pharmaceutical Sciences 8 (2005), 1–9.
39. Núñez-Sánchez, M.A., Garcia-Villalba, R., Monedero-Saiz, T., Garcia-Talavera, N.V., Gomez-Sánchez, M.B., Sánchez-Alvarez, C., et al. Targeted metabolic profiling of pomegranate polyphenols and urolithins in plasma, urine and colon tissues from colorectal cancer patients. Molecular Nutrition and Food Research 58 (2014), 1199–1211.
40. Núñez-Sánchez, M.T., Karmokar, A., González-Sarrías, A., García-Villalba, R., Tomás-Barberán, F.A., García-Conesa, M.T., et al. In vivo relevant mixed urolithins and ellagic acid inhibit phenotypic and molecular colon cancer stem cell features: A new potentiality for ellagitannin metabolites against cancer. Food and Chemical Toxicology 92 (2016), 8–16.
41. O'Leary, K.A., Day, A.J., Needs, P.W., Mellon, F.A., O'Brien, N.M., Williamson, G., Metabolism of quercetin-7- and quercetin-3-glucuronides by an in vitro hepatic model: The role of human b-glucuronidase, sulfotransferase, catechol-O-methyltransferase and multi-resistant protein 2 (MRP2) in flavonoid metabolism. Biochemical Pharmacology 65 (2003), 479–491.
42. Patel, K.R., Andreadi, C., Britton, R.G., Horner-Glister, E., Karmokar, A., Sale, S., et al. Sulfate metabolites provide an intracellular pool for resveratrol generation and induce autophagy with senescence. 205ra133 Science Translational Medicine, 5, 2013.
43. Perez-Vizcaino, F., Duarte, J., Santos-Buelga, C., The flavonoid paradox: Conjugation and deconjugation as key steps for the biological activity of flavonoids. Journal of the Science of Food and Agriculture 92 (2012), 1822–1825.
44. Piwowarski, J.P., Granica, S., Kiss, A.K., Influence of gut microbiota-derived ellagitannins metabolites urolithins on pro-inflammatory activities of human neutrophils. Planta Medica 80 (2014), 887–895.
45. Proteggente, A.R., Basu-Modak, S., Kuhnle, G., Gordon, M.J., Youdim, K., Tyrrell, R., et al. Hesperetin glucuronide, a photoprotective agent arising from flavonoid metabolism in human skin fibroblasts. Photochemistry and Photobiology 78 (2003), 256–261.
46. Rodríguez-Mateos, A., Toro-Funes, N., Cifuentes-Gomez, T., Cortese-Krott, M., Heiss, C., Spencer, J.P., Uptake and metabolism of (-)-epicatechin in endothelial cells. Archives of Biochemistry and Biophysics 559 (2014), 17–23.
47. Rodríguez-Mateos, A., Vauzour, D., Krueger, C.G., Shanmuganayagam, D., Reed, J., Calani, L., et al. Bioavailability, bioactivity and impact on health of dietary flavonoids and related compounds: An update. Archives of Toxicology 88 (2014), 1803–1853.
48. Sabolovic, N., Magdalou, J., Netter, P., Abid, A., Nonsteroidal anti-inflammatory drugs and phenols glucuronidation in Caco-2 cells: Identification of the UDP-glucuronosyltransferases UGT1A6, 1A3 and 2B7. Life Sciences 67 (2000), 185–196.
49. Sala, R., Mena, P., Savi, M., Brighenti, F., Crozier, A., Miragoli, M., et al. Urolithins at physiological concentrations affect the levels of pro-inflammatory cytokines and growth factor in cultured cardiac cells in hyperglucidic conditions. Journal of Functional Foods 15 (2015), 97–105.
50. Spencer, J.P.E., Abd El Mohsen, M.M., Rice-Evans, C., Cellular uptake and metabolism of flavonoids and their metabolites: Implications for their bioactivity. Archives of Biochemistry and Biophysics 423 (2004), 148–161.
51. Spencer, J.P.E., Kuhnle, G.G.C., Williams, R.J., Rice-Evans, C., Intracellular metabolism and bioactivity of quercetin and its in vivo metabolites. Biochemical Journal 372 (2003), 173–181.
52. Spencer, J.P.E., Schroeter, H., Crossthwaithe, A.J., Kuhnle, G., Williams, R.J., Rice-Evans, C., Contrasting influences of glucuronidation and O-methylation of epicatechin on hydrogen peroxide-induced cell death in neurons and fibroblasts. Free Radical Biology and Medicine 31 (2001), 1139–1146.
53. Spigoni, V., Mena, P., Cito, M., Fantuzzi, F., Bonadonna, R.C., Brighenti, F., et al. Effects on nitric oxide production of urolithins, gut-derived ellagitannin metabolites, in human aortic endothelial cells. Molecules, 21, 2016, 1009.
54. Tribolo, S., Lodi, F., Winterbone, M.S., Saha, S., Needs, P.W., Hughes, D.A., et al. Human metabolic transformation of quercetin blocks its capacity to decrease endothelial nitric oxide synthase (eNOS) expression and endothelin-1 secretion by human endothelial cells. Journal of Agricultural and Food Chemistry 61 (2013), 8589–8596.
55. Vafeiadou, K., Vauzour, D., Rodríguez-Mateos, A., Whiteman, M., Williams, R.J., Spencer, J.P.E., Glial metabolism of quercetin reduces its neurotoxic potential. Archives of Biochemistry and Biophysics 478 (2008), 195–200.
56. Warner, E.F., Zhang, Q.Z., Raheem, K.S., O'Hagan, D., O'Connell, M.A., Kay, C.D., Common phenolic metabolites of flavonoids, but not their unmetabolized precursors, reduce the secretion of vascular cellular adhesion molecules by human endothelial cells. Journal of Nutrition 146 (2016), 465–473.
57. Wilkening, S., Stahl, F., Bader, A., Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metabolism and Disposition 31 (2003), 1035–1042.
58. Wong, C.C., Williamson, G., Inhibition of hydroxycinnamic acid sulfation by flavonoids and their conjugated metabolites. Biofactors 39 (2013), 644–651.
59. Wong, Y.C., Zhang, L., Lin, G., Zuo, Z., Structure–activity relationships of the glucuronidation of flavonoids by human glucuronosyltransferases. Expert Opinion on Drug Metabolism & Toxicology 5 (2009), 1399–1419.
60. van der Woude, H., Boersma, M.G., Vervoort, J., Rietjens, I.M., Identification of 14 quercetin phase II mono- and mixed conjugates and their formation by rat and human phase II in vitro model systems. Chemical Research in Toxicology 17 (2004), 1520–1530.
61. Wu, B., Kulkarni, K., Basu, S., Zhang, S., Hu, M., First-pass metabolism via UDP-glucuronosyltransferase: A barrier to oral bioavailability of phenolics. Journal of Pharmaceutical Sciences 100 (2011), 3655–3681.
62. Xiao, J., Högger, P., Stability of dietary polyphenols under the cell culture conditions: Avoiding erroneous conclusions. Journal of Agricultural and Food Chemistry 63 (2015), 1547–1557.
63. Yoshino, K., Suzuki, M., Sasaki, K., Miyase, T., Sano, M., Formation of antioxidants from (−)-epigallocatechin gallate in mild alkaline fluids, such as authentic intestinal juice and mouse plasma. The Journal of Nutritional Biochemistry 10 (1999), 223–229.
64. Zanotti, I., Dall'Asta, M., Mena, P., Mele, L., Bruni, R., Ray, S., et al. Atheroprotective effects of (poly)phenols: A focus on cell cholesterol metabolism. Food & Function 6 (2015), 13–31.